Menu Philippe 4
4 · SOPHiA GENETICS SA · Filed May 20, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CMO Philippe Menu Sells 608 Shares
What Happened
- Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 608 shares in an open-market transaction on May 19, 2026. The weighted-average sale price was $4.61 per share for a reported total of approximately $2,800. This was a sale (code S) executed to satisfy tax withholding tied to RSUs that vested on May 18, 2026, and therefore is a routine, non-discretionary transaction under a pre-established Rule 10b5-1(c) plan.
Key Details
- Transaction date: 2026-05-19; weighted average price: $4.61; reported total proceeds: $2,800.
- Price range: shares were sold in multiple trades at prices from $4.54 to $4.66 (inclusive). The filer can provide a breakdown of the number sold at each price upon written request (see footnote F2).
- Reason: Sales were made to satisfy tax withholding on RSU vesting on 2026-05-18 and were effected under a pre-established Rule 10b5-1(c) plan (footnote F1).
- Shares owned after transaction: not disclosed in the provided filing details.
- Filing: Form 4 filed 2026-05-20 for a 2026-05-19 transaction — filed the next day (timely).
Context
- These sales were tax-withholding related and governed by a 10b5-1 plan, meaning they were pre-set and not discretionary trades by the insider. Such routine sell-to-cover transactions generally do not signal a change in insider confidence.
Insider Transaction Report
Form 4
Menu Philippe
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-05-19$4.61/sh−608$2,800→ 255,780 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Elimara Brunetto as Attorney-in-fact for Philippe Menu|2026-05-20